Placenta protein study completed: no new treatment yet
NCT ID NCT06849349
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study examined levels of certain proteins and growth factors in the placentas of 48 women with placenta previa or placenta percreta during the third trimester. Researchers measured substances like decorin, laminin, and collagen in placental tissue and blood samples. The goal was to better understand these pregnancy complications, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLACENTA PERCRETA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Manisa Celal Bayar University
Manisa, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple silicone ring prevent dangerous bleeding in pregnancy?
- New study aims to predict dangerous placenta complications before delivery
- New trial aims to find best drug to stop bleeding in High-Risk C-Sections
- Blood protein may spot hidden pregnancy danger
- Coloring away fear: mandala therapy eases childbirth anxiety in High-Risk pregnancies
- Ultrasound score may guide surgery for dangerous placenta condition